Deborah J. Wong, MD, PhD

1. Wong, D.L., Rao, A.,  Avramis, E., Matsunaga, D.R , Komatsubara, K.M., Chodon, T. , Koya, R.C., Ribas, A.  and Comin-Anduix, B.  组蛋白去乙酰化酶抑制剂对人淋巴细胞的有害影响.  Cancer Immunol Res, 2014, May 2014 2; 459.
2. Atefi, M., Avramis, E., Lassen, A., Wong, D.J., Robert, L., Foulad, D., Cerniglia, M., Titz, B., Chodon, T., Graeber, T.G., Comin-Anduix, B., Ribas, A.MAPK和PI3K通路对黑色素瘤中PD-L1表达的影响. Clinical Cancer Research. 2014, May 8. PMID: 24812408.
3. Wong DJ, Robert L, Atefi MS, Lassen A, Avarappatt G, Cerniglia M, Avramis E, Tsoi J, Foulad D, Graeber TG, Comin-Anduix B, Samatar A, Lo RS, Ribas A. ERK抑制剂SCH722984对BRAF突变体的抗肿瘤活性, NRAS mutant and wild-type melanoma. Mol Cancer. 2014 Aug 20;13:194. PMID: 25142146.
4. Atefi, M.S., Titz, B., Avramis, E., Ng, C., Wong, D.J.L., Lassen, A., Cerniglia, M., Escuin-Ordinas, H., Foulad, D., Comin-Anduix, B., Graeber, T., and Ribas, A.  泛raf和MEK抑制剂在NRAS突变黑色素瘤细胞系中的联合应用. Mol Cancer. 2015 Feb 3;14:27. PMID: 25645078
5. Warner WA, Wong DJ, Palma-Diaz F, Shibuya TY, Momand J. 转移性腮腺腺泡细胞癌ARID2无义突变和CDKN2A/B缺失患者的临床病理和靶向外显子组基因特征. Case Rep Oncol Med. 2015;2015:  PMID:  26634163
6. Hu, S.B. Wong, D.J.L., Anath, A., Li, N., and Deng, J.C.  神经网络模型预测成人血液系统恶性肿瘤住院患者临床恶化.  PLOS One, 2016 Aug 17;11(8). PMID: 27532679
7. Naing A, Papadopoulos KP, Autio KA, Ott PA, Patel MR, Wong DJ, Falchook GS, Pant S, Whiteside M, Rasco DR, Mumm JB, Chan IH, Bendell JC, Bauer TM, Colen RR, Hong DS, Van Vlasselaer P, Tannir NM, Oft M, Infante JR.  Safety, Antitumor Activity, 聚乙二醇化重组人白细胞介素-10 (AM0010)在晚期实体瘤患者中的免疫激活.  J Clin Oncol. 2016 Aug 15. PMID: 27528724.
8. 陈安，Felix C, Wang PC, Hsu S, Basehart V, Garst J, Beron P， Wong D， Rosove MH, Rao S, Melanson H, Kim E, Palmer D, Qi L, Kelly K, Steinberg ML, Kupelian PA, Daly ME.  口咽部乳头状瘤病毒相关鳞状细胞癌的低剂量放疗:单组研究, phase 2 study.  Lancet Oncol. 2017 Apr 20. pii: S1470-2045(17)30246-2. PMID:  28434660.
9. Gulley JL, Rajan A, Spigel DR, Iannotti N, Chandler J， Wong DJL， Leach J, Edenfield WJ, Wang D, Grote HJ, Heydebreck AV, chink, Cuillerot JM, Kelly K.  Avelumab用于既往治疗的转移性或复发性非小细胞肺癌(JAVELIN实体瘤)患者:一项多中心剂量扩展队列研究, open-label, phase 1b trial.  Lancet Oncol. 2017 May;18(5):599-610.  PMID:  28373005.
10. Spiegel ML, Goldman JW, Wolf BR, Nameth DJ, Grogan TR, Lisberg AE, Wong DJL, Ledezma BA, Mendenhall MA, Genshaft SJ, Gutierrez AJ, Abtin F, Wallace WD, Adame CR, McKenzie JR, Abarca PA, Li AJ, Strunck JL, Famenini S, Carroll JM, Tucker DA, Sauer LM, Moghadam NM, Elashoff DA, Abaya CD, Brennan MB, Garon EB.  非小细胞肺癌临床试验需要活检和生物标志物特异性结果的登记提供了独特的挑战. Cancer. 2017 Dec 15;123(24):4800-4807.  PMID: 29125624.
11. Hegde JV, Shaverdian N, Daly ME, Felix C, Wong DL, Rosove MH, Garst JH, Wang PC, Veruttipong D, Rao S, Fragoso RC, Riess JW, Steinberg ML, Chen AM.  人乳头瘤病毒阳性口咽癌降压放化疗后患者报告的生活质量:一项2期试验的结果. Cancer. 2017 Oct 17. PMID: 29044458
12. Sullivan RJ, Infante JR, Janku F, Wong DJL, Sosman JA, Keedy V, Patel MR, Shapiro GI, Mier JW, Tolcher AW, Wang-Gillam A, Sznol M, Flaherty K, Buchbinder E, Carvajal RD, Varghese AM, Lacouture ME, Ribas A, Patel SP, DeCerescenzo GA, Emery CM, Groover AL, Saha S, Varterasian M, Welsch DJ, Hyman DM, Li BT.  ERK1/2抑制剂乌利昔替尼(BVD-523)用于MAPK突变的晚期实体瘤患者:一项I期剂量递增和扩展研究的结果.  Cancer Discov. 2018 Feb;8(2):184-195. doi: 10.1158/2159-8290.CD-17-1119. Epub 2017 Dec 15.  PMID: 29247021.
13. Atkins M, Hodi FS, Thompson J, McDermott D, Hwu W, Lawrence D, Dawson N， Wong D, Bhatia S, JamesM, Jain L, Robey S, Shu X, Homet Moreno B, Perini R, Choueiri T, Ribas A.  Pembrolizumab联合聚乙二醇化干扰素α -2b或ipilimumab治疗晚期黑色素瘤或肾细胞癌:1b期KEYNOTE-029研究的剂量发现结果.   Clin Cancer Res. 2018 Apr 15;24(8):1805-1815. doi: 10.1158/1078-0432.CCR-17-3436. Epub 2018 Jan 22. PMID 29358500
14. Kelly K, Infante JR, Taylor MH, Patel MR, Wong DJ, Iannotti N, Mehnert JM, Loos AH, Koch H, Speit I, Gulley JL.  avelumab在晚期实体瘤患者中的安全性:来自JAVELIN实体瘤i期和JAVELIN Merkel 200期临床试验数据的汇总分析.  Cancer 2018 May 1;124(9):2010-2017. doi: 10.1002/cncr.31293. Epub 2018 Feb 22.PMID 29469949
15. 蔡俊，李国强，张国强，张国强，张国强，李志强， Wong DJL, Atefi M, Shirazi R, Wang X, Braas D, Grasso CS, Palaskas N, Ribas A, Graeber TG.  多阶段分化定义黑色素瘤亚型对药物诱导的铁依赖性氧化应激的不同易感性. Cancer Cell. 2018 May 14;33(5):890-904.e5. doi: 10.1016/j.ccell.2018.03.017. Epub 2018 Apr 12.PMID 29657129.
16. Ribas A, Medina T, Kummar S, Amin A, Kalbasi A, Drabick JJ, Barve M, Daniels GA， Wong DJ, Schmidt EV, canadian AF, Coffman RL, Leung ACF, Janssen RS.  SD-101联合派姆单抗治疗晚期黑色素瘤:Ib期研究结果, Multicenter Study.  Cancer Discov. 2018 Oct;8(10):1250-1257. doi: 10.1158/2159-8290.CD-18-0280. Epub 2018 Aug 28. PMID  30154193.

See more publications.

• 轮到我了:如果你听到那些可怕的话:你得了癌症 (Daily Breeze)
• 在大流行期间获得IV期甲状腺髓样癌的临床试验-癌症进展报告 (aacr.org)

• huijiezdh.com/community-cancercare
• huijiezdh.com/community-cancercare/santa-monica
• huijiezdh.com/community-cancercare/torrance
• huijiezdh.com/community-cancercare/westwood
• huijiezdh.com/lungcancer
• huijiezdh.com/torrance